{
    "Trade/Device Name(s)": [
        "SAFECARE Urine Test Amphetamine (Cassette, Cup, DipCard)",
        "SAFECARE Urine Test Cocaine (Cassette, Cup, DipCard)",
        "SAFECARE Urine Test Marijuana (Cassette, Cup, DipCard)"
    ],
    "Submitter Information": "Safecare Biotech Co. Ltd.",
    "510(k) Number": "K153646",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DKZ",
        "LDJ"
    ],
    "Summary Letter Date": "December 15, 2015",
    "Summary Letter Received Date": "December 21, 2015",
    "Submission Date": "March 17, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3250",
        "21 CFR 862.3100",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Cocaine and Cocaine Metabolite Test System",
        "Amphetamine Test System",
        "Cannabinoid Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Benzoylecgonine",
        "11-nor-\u03949-THC-9 COOH",
        "Cannabinoids"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Cassette",
        "Cup",
        "DipCard"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Competitive binding immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Specimen collection device",
        "Cassette",
        "Cup",
        "DipCard"
    ],
    "Document Summary": "FDA 510(k) summary for SAFECARE urine tests for qualitative detection of amphetamine, cocaine metabolite, and cannabinoids using immunochromatographic lateral flow assay formats (cassette, cup, dipcard).",
    "Indications for Use Summary": "Qualitative detection of amphetamine, benzoylecgonine, and cannabinoids in human urine at specified cutoffs; provides preliminary screening, for prescription and over-the-counter in vitro diagnostic use.",
    "fda_folder": "Toxicology"
}